Helsinn Healthcare Sustainability Profile
Helsinn Healthcare, a Swiss-based pharmaceutical company, has established itself as a leader in the oncology and supportive care sectors since its founding in 1977. Headquartered in Lugano, Switzerland, Helsinn operates globally, with significant presence in Europe, North America, and Asia. The company is renowned for its innovative approach to developing high-quality products that enhance the quality of life for cancer patients, including its flagship anti-emetic treatments. With a strong commitment to research and development, Helsinn has achieved notable milestones, including strategic partnerships and a robust pipeline of therapies. Its dedication to patient-centric solutions and a focus on unmet medical needs have positioned Helsinn as a trusted name in the healthcare industry, recognised for its contributions to cancer care and supportive therapies.
DitchCarbon Score
How does Helsinn Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Helsinn Healthcare's score of 31 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Helsinn Healthcare's reported carbon emissions
In 2023, Helsinn Healthcare reported total carbon emissions of approximately 1,000,000 kg CO2e, with significant contributions from Scope 3 emissions, which accounted for about 1,500,000 kg CO2e. Specifically, Scope 1 emissions were about 89,980 kg CO2e, while Scope 2 emissions totalled approximately 144,970 kg CO2e. The breakdown of Scope 3 emissions included capital goods (about 848,910 kg CO2e), business travel (approximately 88,260 kg CO2e), and employee commuting (around 315,150 kg CO2e). In 2022, the company reported Scope 1 emissions of about 36,650 kg CO2e, Scope 2 emissions of approximately 300 kg CO2e, and a substantial Scope 3 total of about 3,601,250 kg CO2e. The 2021 data indicated total emissions of approximately 3,370,000 kg CO2e, with Scope 1 emissions at about 1,175,000 kg CO2e and Scope 2 emissions around 340,000 kg CO2e. Helsinn Healthcare has not set specific reduction targets or initiatives as part of the Science Based Targets initiative (SBTi) or other climate pledges. The company’s emissions data is not cascaded from a parent organization, indicating that it operates independently in its reporting and climate commitments. Overall, Helsinn Healthcare's emissions profile highlights a significant reliance on Scope 3 emissions, particularly from capital goods and employee commuting, underscoring the need for targeted strategies to address these areas in future sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2012 | 2013 | 2014 | 2015 | 2016 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 2,955 | 0,000 | 0,000 | 0,000 | 0,000 | 0,000,000 | 00,000 | 00,000 |
| Scope 2 | - | - | - | - | - | 000,000 | 000 | 000,000 |
| Scope 3 | - | - | - | - | - | 0,000,000 | 0,000,000 | 0,000,000 |
How Carbon Intensive is Helsinn Healthcare's Industry?
How Carbon Intensive is Helsinn Healthcare's Location?
Helsinn Healthcare's Scope 3 Categories Breakdown
Helsinn Healthcare's Scope 3 emissions, which decreased by 55% last year and decreased by approximately 12% since 2021, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Capital Goods" being the largest emissions source at 52% of Scope 3 emissions.
Top Scope 3 Categories
Helsinn Healthcare's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Helsinn Healthcare has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
